Injectable vs Oral GS-441524: Which Form Works Best for Your Cat
One of the first practical decisions after an FIP diagnosis is how to administer GS-441524. The drug is available in two forms: subcutaneous injectable and oral capsules. Both contain the same active compound. Both follow the same 84-day protocol. But they are not interchangeable in every situation — and choosing the wrong form at the wrong time can affect whether treatment works.
This guide explains how each form works, what the clinical differences are, and how to decide which is right for your cat’s specific situation.
How Each Form Works
Injectable GS-441524 is administered as a subcutaneous injection — under the skin, typically at the scruff of the neck or along the back. The drug is absorbed directly from the subcutaneous tissue into the bloodstream, bypassing the gastrointestinal tract entirely. This means the amount of drug that reaches the bloodstream is predictable, consistent, and unaffected by what is happening in the cat’s stomach or intestines.
Oral GS-441524 capsules are swallowed and absorbed through the gastrointestinal tract. The drug passes through the stomach and intestinal wall before entering the bloodstream. This route is less invasive and easier for some owners to administer — but it introduces variables that the injectable route does not have.
The landmark Pedersen et al. 2019 UC Davis trial (J Feline Med Surg) that established GS-441524 as the standard of care for FIP used the injectable form exclusively. The 92% success rate documented in that study reflects injectable administration at the correct dose for the full 84-day protocol.
The Core Clinical Difference: Absorption Reliability
The most important difference between injectable and oral GS-441524 is not convenience or cost — it is absorption reliability.
With injectable GS-441524, the therapeutic drug level in the bloodstream is achieved consistently, every day, regardless of the cat’s gastrointestinal status. Vomiting, diarrhoea, reduced gastric motility, or poor appetite do not affect how much drug reaches the bloodstream.
With oral GS-441524, absorption depends on the gastrointestinal tract functioning normally. If a cat is vomiting — common in FIP, particularly in the early weeks of treatment — the capsule may be expelled before absorption is complete. If gastric motility is reduced by illness or inflammation, absorption may be slower and less complete. If the cat is not eating, the capsule may not be taken at all.
Inconsistent drug levels mean inconsistent viral suppression. And inconsistent viral suppression gives the FIP virus opportunities to replicate — potentially reducing treatment efficacy or, in the worst case, contributing to resistance.
This is why the choice between injectable and oral is not simply a matter of owner preference. It is a clinical decision based on the cat’s condition.
When Injectable GS-441524 Is Essential
Injectable GS-441524 should be the starting form — and may need to remain the form throughout the full 84 days — in the following situations:
Severe or rapidly progressing FIP. Wet FIP with significant fluid accumulation, neurological FIP, and any cat that is critically unwell at diagnosis needs the most reliable drug delivery possible. Injectable GS-441524 reaches therapeutic levels in the bloodstream faster and more consistently than oral capsules. In a cat that is days from critical deterioration, this speed and reliability matters.
Vomiting. Any cat that is vomiting during treatment must be on injectable GS-441524. If a cat vomits after taking an oral capsule — particularly within 30 minutes of administration — the dose is likely incomplete. Repeated incomplete doses mean the virus is not being suppressed effectively. Read our guide on cat vomiting during FIP treatment for a full explanation of why this matters and what to do.
Diarrhoea or gastrointestinal disease. Diarrhoea accelerates gastrointestinal transit, reducing the time available for oral drug absorption. Concurrent inflammatory bowel disease or pancreatitis — conditions that can coexist with FIP — further compromise absorption. Injectable GS-441524 is not affected by any of these.
Poor appetite or refusal to eat. A cat that is not eating reliably cannot be given oral capsules reliably. Injectable GS-441524 is administered regardless of whether the cat has eaten.
Neurological FIP. Neurological FIP requires the highest dose of GS-441524 (10 mg/kg daily) to achieve therapeutic levels in the central nervous system. The ABCD (Advisory Board on Cat Diseases) FIP guidelines note that neurological FIP requires consistent, reliable drug delivery — making injectable the preferred form. Read our guide to neurological FIP for more detail.
Ocular FIP. Similarly, ocular FIP requires 10 mg/kg daily and consistent drug levels to achieve therapeutic concentrations in the eye. Injectable is preferred.
When Oral GS-441524 May Be Appropriate
Oral GS-441524 capsules are a legitimate option in specific circumstances — not a compromise, but a clinically appropriate choice when the conditions are right:
Mild to moderate wet or dry FIP in a cat that is eating well and not vomiting. A cat with early-stage FIP, good appetite, no gastrointestinal symptoms, and a cooperative temperament for capsule administration may do well on oral GS-441524 from the start.
Transition from injectable after clinical stabilisation. Some cats begin on injectable GS-441524 for the first 4 to 8 weeks — until fever has resolved, appetite has returned, and the cat is clinically stable — and then transition to oral capsules for the remainder of the 84-day protocol. This approach combines the reliability of injectable during the critical early phase with the convenience of oral during the stable recovery phase.
Owner inability to administer injections. Some owners are not comfortable or able to administer daily subcutaneous injections. In this case, oral GS-441524 with close veterinary monitoring is preferable to no treatment or inconsistent injectable administration. If oral is chosen for this reason, the cat’s gastrointestinal status must be monitored carefully throughout treatment.
Dosing: The Same Drug, the Same Protocol
The dose of GS-441524 is the same regardless of whether injectable or oral form is used — calculated by body weight and FIP form:
| FIP Form | Daily Dose | Injectable Product | Duration |
|---|---|---|---|
| Wet (Effusive) | 6 mg/kg | GS-441524 20 mg/ml | 84 days |
| Dry (Non-effusive) | 8 mg/kg | GS-441524 20 mg/ml | 84 days |
| Ocular | 10 mg/kg | GS-441524 30 mg/ml | 84 days |
| Neurological | 10 mg/kg | GS-441524 30 mg/ml | 84 days |
Dosing follows Pedersen et al., UC Davis (PMC6435921). Your veterinarian confirms form and weight before the first dose.
Under-dosing is the most common cause of treatment failure and relapse — regardless of whether injectable or oral form is used. Getting the dose right from day one is more important than the choice of administration route.
Practical Tips for Injectable Administration
For owners new to subcutaneous injections, the process becomes routine within a few days. Key points:
- Allow the solution to reach room temperature before injecting — cold solution causes more discomfort and local reaction
- Rotate injection sites daily — do not inject the same spot two days in a row. Use the scruff, the sides of the neck, and the skin along the back in rotation
- Inject slowly and steadily — rapid injection increases discomfort and local reaction
- Gently massage the site after injection to disperse the solution
- Use a favourite treat immediately after to create a positive association with injection time
- Keep the process calm and consistent — same time each day, same routine, minimal restraint
For a full guide to managing injection site reactions and other side effects during treatment, read our GS-441524 side effects guide.
Monitoring Treatment Response
Regardless of which form is used, the markers of treatment response are the same: fever resolution within 7 to 14 days, returning appetite, weight stabilisation, and improving blood work at day 30. For a full explanation of what improving blood markers look like at each stage, read our complete blood work guide for FIP cat owners.
If a cat on oral GS-441524 is not showing clinical improvement by day 14, the first question to ask is whether absorption is reliable. Switching to injectable and reassessing at day 30 is often the right next step before concluding that the dose needs to be increased.
Frequently Asked Questions
Is injectable GS-441524 more effective than oral?
Both deliver the same drug. The difference is absorption reliability. In cats with normal gastrointestinal function who are eating well and not vomiting, oral GS-441524 can be equally effective. In cats with GI symptoms, severe FIP, or neurological/ocular involvement, injectable is more reliable and therefore clinically preferable.
Can I switch from injectable to oral during the 84-day protocol?
Yes, in appropriate cases. Many cats start on injectable for the first 4 to 8 weeks until clinically stable, then transition to oral for the remainder of the protocol. The transition should be made with veterinary guidance and the cat’s GI status should be confirmed as normal before switching.
My cat vomited after taking the oral capsule. What do I do?
If vomiting occurred within 30 minutes of the capsule being given, absorption is likely incomplete. Do not give another capsule the same day. Contact your vet and discuss switching to injectable GS-441524. Read our vomiting during FIP treatment guide for full guidance.
Is injectable GS-441524 painful for cats?
The injection causes brief, mild discomfort — similar to any subcutaneous injection. Most cats tolerate it well with good technique, site rotation, and room-temperature solution. The discomfort is transient and does not affect the cat’s willingness to be handled between injections in most cases.
Can I learn to give the injections myself at home?
Yes. Most owners learn subcutaneous injection technique quickly with guidance from their vet. Home administration is standard practice for the 84-day protocol — daily vet visits for injections are not necessary or practical. Your vet or veterinary nurse can demonstrate the technique at the first appointment.
What if my cat absolutely will not tolerate injections?
Discuss with your vet. If the cat’s GI status is normal and FIP is not severe, oral GS-441524 with close monitoring is a legitimate alternative. The priority is consistent daily dosing — whichever form achieves that most reliably for your specific cat is the right choice.
The choice between injectable and oral GS-441524 is not about which is better in the abstract — it is about which delivers consistent therapeutic drug levels in your cat’s specific clinical situation. For most cats with serious FIP symptoms, injectable is the right starting point. For cats that are clinically stable and eating well, oral may be appropriate. When in doubt, injectable is the safer choice.
For the complete step-by-step guide from diagnosis to completing the protocol, read our FIP action guide. Questions about which product is right for your cat? The FIP CURE Plus team is available in English and Arabic at info@fipcureplus.com.
View the FIP CURE Plus GS-441524 injectable range →
FIP CURE Plus — transparent, evidence-based GS-441524 treatment for cats across the Gulf.